These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26446055)

  • 1. Platelet components associated with adverse reactions: predictive value of mitochondrial DNA relative to biological response modifiers.
    Cognasse F; Aloui C; Anh Nguyen K; Hamzeh-Cognasse H; Fagan J; Arthaud CA; Eyraud MA; Sebban M; Fromont E; Pozzetto B; Laradi S; Garraud O
    Transfusion; 2016 Feb; 56(2):497-504. PubMed ID: 26446055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Removal by adsorbent beads of biological response modifiers released from platelets, accumulated during storage, and potentially associated with platelet transfusion reactions.
    Tanaka S; Hayashi T; Tani Y; Hirayama F
    Transfusion; 2010 May; 50(5):1096-105. PubMed ID: 20051054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune-reactive soluble OX40 ligand, soluble CD40 ligand, and interleukin-27 are simultaneously oversecreted in platelet components associated with acute transfusion reactions.
    Hamzeh-Cognasse H; Damien P; Nguyen KA; Arthaud CA; Eyraud MA; Chavarin P; Absi L; Osselaer JC; Pozzetto B; Cognasse F; Garraud O
    Transfusion; 2014 Mar; 54(3):613-25. PubMed ID: 23944651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Removal of biological response modifiers associated with platelet transfusion reactions by columns containing adsorption beads.
    Tanaka S; Hayashi T; Tani Y; Hirayama F
    Transfusion; 2014 Jul; 54(7):1790-7. PubMed ID: 24417744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pooling, room temperature, and extended storage time increase the release of adult-specific biologic response modifiers in platelet concentrates: a hidden transfusion risk for neonates?
    Waubert de Puiseau M; Sciesielski LK; Meyer O; Liu ZJ; Badur CA; Schönfeld H; Tauber R; Pruß A; Sola-Visner MC; Dame C
    Transfusion; 2020 Aug; 60(8):1828-1836. PubMed ID: 32339309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet products prepared by different methods of sedimentation undergo platelet activation differently during storage.
    Skripchenko A; Kurtz J; Moroff G; Wagner SJ
    Transfusion; 2008 Jul; 48(7):1469-77. PubMed ID: 18482181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions.
    Blumberg N; Gettings KF; Turner C; Heal JM; Phipps RP
    Transfusion; 2006 Oct; 46(10):1813-21. PubMed ID: 17002639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged platelet storage associated with increased frequency of transfusion-related adverse events.
    Losos M; Biller E; Li J; Blower L; Hamad D; Patel G; Scrape S; Cataland S; Chen J
    Vox Sang; 2018 Feb; 113(2):170-176. PubMed ID: 29243264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amotosalen-HCl-UVA pathogen reduction does not alter poststorage metabolism of soluble CD40 ligand, Ox40 ligand and interkeukin-27, the cytokines that generally associate with serious adverse events.
    Hamzeh-Cognasse H; Laradi S; Osselaer JC; Cognasse F; Garraud O
    Vox Sang; 2015 Feb; 108(2):205-7. PubMed ID: 25334045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release of potential immunomodulatory factors during platelet storage.
    Cognasse F; Boussoulade F; Chavarin P; Acquart S; Fabrigli P; Lamy B; Garraud O
    Transfusion; 2006 Jul; 46(7):1184-9. PubMed ID: 16836566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling the effect of platelet concentrate supernatants on endothelial cells: focus on endocan/ESM-1.
    Tariket S; Sut C; Arthaud CA; Eyraud MA; Meneveaux A; Laradi S; Hamzeh-Cognasse H; Garraud O; Cognasse F
    Transfusion; 2018 Feb; 58(2):439-445. PubMed ID: 29238987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A computerized prediction model of hazardous inflammatory platelet transfusion outcomes.
    Nguyen KA; Hamzeh-Cognasse H; Sebban M; Fromont E; Chavarin P; Absi L; Pozzetto B; Cognasse F; Garraud O
    PLoS One; 2014; 9(5):e97082. PubMed ID: 24830754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial damage-associated molecular patterns as potential proinflammatory mediators in post-platelet transfusion adverse effects.
    Yasui K; Matsuyama N; Kuroishi A; Tani Y; Furuta RA; Hirayama F
    Transfusion; 2016 May; 56(5):1201-12. PubMed ID: 26920340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A tight interplay between platelet activation and mitochondrial DNA release promotes platelet storage lesion in platelet concentrates.
    Haeri K; Samiee S; Beigi P; Hajati S; Deyhim MR
    Vox Sang; 2024 May; 119(5):439-446. PubMed ID: 38385820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet concentrate supernatants alter endothelial cell mRNA and protein expression patterns as a function of storage length.
    Sut C; Hamzeh-Cognasse H; Arthaud CA; Eyraud MA; Chettab K; Dumontet C; Laradi S; Burnouf T; Garraud O; Cognasse F
    Transfusion; 2018 Nov; 58(11):2635-2644. PubMed ID: 30325037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of platelet-derived microparticles in stored apheresis platelet concentrates on polymorphonuclear leucocyte respiratory burst.
    Xie RF; Hu P; Li W; Ren YN; Yang J; Yang YM; Wang ZY; Fan HH
    Vox Sang; 2014 Apr; 106(3):234-41. PubMed ID: 24138005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the soluble proteins HMGB1, CD40L and CD62P during various platelet preparation processes and the storage of platelet concentrates: The BEST collaborative study.
    Cognasse F; Hamzeh Cognasse H; Eyraud MA; Prier A; Arthaud CA; Tiberghien P; Begue S; de Korte D; Gouwerok E; Greinacher A; Aurich K; Noorman F; Dumont L; Kelly K; Cloutier M; Bazin R; Cardigan R; Huish S; Smethurst P; Devine D; Schubert P; Johnson L; Marks DC;
    Transfusion; 2023 Jan; 63(1):217-228. PubMed ID: 36453841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-derived extracellular vesicles convey mitochondrial DAMPs in platelet concentrates and their levels are associated with adverse reactions.
    Marcoux G; Magron A; Sut C; Laroche A; Laradi S; Hamzeh-Cognasse H; Allaeys I; Cabon O; Julien AS; Garraud O; Cognasse F; Boilard E
    Transfusion; 2019 Jul; 59(7):2403-2414. PubMed ID: 30973972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet transfusion alters CD40L blood level and release capacity in patients suffering from thrombocytopenia.
    Wenzel F; Günther W; Baertl A; Gruber W; Sorg RV; Haas R; Giers G
    Transfusion; 2012 Jun; 52(6):1213-20. PubMed ID: 22082313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of immune modulation factors from platelet concentrates during storage after photochemical pathogen inactivation treatment.
    Cognasse F; Osselaer JC; Payrat JM; Chavarin P; Corash L; Garraud O
    Transfusion; 2008 May; 48(5):809-13. PubMed ID: 18298593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.